Valuation Actinium Pharmaceuticals, Inc.

Stocks

Market Closed - NYSE Other stock markets 16:00:00 2026-07-17 EDT			5-day change	1st Jan Change
0.9219 ^USD	+3.58%		-0.87%	-32.21%

06-03	Actinium Pharmaceuticals Presents New Data on Atnm-400 Demonstrating Potent Activity in Prostate Cancer Models Resistant to All Three Approved Androgen Receptor Inhibitors	CI
06-01	Actinium Pharmaceuticals, Inc. Appoints Steffen Heeger as Chief Medical Officer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	132.4	271.4	139.3	39.31	42.43	28.92	-	-
Change	-	104.97%	-48.69%	-71.77%	7.94%	-31.82%	-	-
Enterprise Value (EV)	132.4	271.4	62.58	39.31	42.43	28.92	28.92	28.92
Change	-	104.97%	-76.94%	-37.19%	7.94%	-31.82%	0%	0%
P/E	-5.01x	-7.77x	-2.78x	-0.99x	-1.25x	-1.09x	-1.65x	-3.74x
PBR	1.81x	-	3.72x	-	-	-	-	-
PEG	-	-0.5x	-0.1x	0x	0.1x	0x	0x	0.1x
Capitalization / Revenue	116x	263x	1,719x	-	471x	-	2.24x	0.84x
EV / Revenue	0x	0x	0x	-	0x	-	2.24x	0.84x
EV / EBITDA	-0x	-0x	-0x	-0x	-0x	-0.95x	-0.83x	-0.76x
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-0.95x	-1.14x	-1.91x
EV / FCF	-0x	0x	-0x	-0x	-	-1.85x	-12.1x	2.24x
FCF Yield	-15.9%	3.05%	-34.1%	-84.2%	-	-54%	-8.3%	44.6%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.2	-1.37	-1.83	-1.27	-1.09	-0.8467	-0.56	-0.2467
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1.144	1.03	0.081	-	0.09	-	12.93	34.58
EBITDA ¹	-24.44	-33.4	-51.13	-41.31	-35.43	-30.5	-34.8	-38.3
EBIT ¹	-24.96	-34.1	-51.92	-42.12	-36.25	-30.5	-25.48	-15.17
Net income ¹	-24.77	-33.02	-48.82	-38.24	-33.89	-28.5	-23.27	-12.34
Net Debt	-	-	-76.68	-	-	-	-	-
Reference price ²	6.0100	10.6500	5.0800	1.2600	1.3600	0.9219	0.9219	0.9219
Nbr of stocks (in thousands)	22,031	25,483	27,413	31,196	31,196	31,375	-	-
Announcement Date	3/25/22	3/31/23	3/29/24	3/31/25	3/30/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ACTINIUM PHARMACEUTICALS, INC.	-1.09x	-	-	-	28.92M
ARGENX SE	32.22x	8.13x	25.24x	0.05%	53.83B
WUXI APPTEC CO., LTD.	19.5x	6.01x	13.15x	1.63%	52.1B
INSMED INCORPORATED	-42.48x	13.5x	-39.59x	-.--%	23.48B
BIONTECH SE	-18.22x	4.32x	-7.57x	-.--%	23.13B
WUXI BIOLOGICS (CAYMAN) INC.	24.24x	4.75x	12.54x	-.--%	19.36B
GENMAB A/S	24.39x	4.78x	15.56x	-.--%	17.56B
PHARMAESSENTIA CORPORATION	45.88x	18.59x	47.88x	0.08%	15.2B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-505.73x	35.47x	-1462.84x	-.--%	14.83B
EXELIXIS, INC.	17.57x	5.11x	11.88x	-.--%	14.06B
Average	-40.37x	11.19x	-153.75x	0.2%	23.36B
Weighted average by Cap.	-18.52x	9.52x	-82.82x	0.38%